PRKAA1 and cancer: They used aminoimidazole carboxamide ribonucleotide (AICAR), a nucleoside analog initially developed as a cardioprotective agent, to activate the AMPK/PGC-1α/TFAM pathway for mitochondrial biogenesis, thereby targeting cancer cell energy metabolism.